Pomerantz Law Firm Launches Investigation into Cerebras Systems Inc. Investor Claims
Pomerantz Law Firm Investigates Cerebras Systems Inc.
Pomerantz LLP, a recognized leader in securities class action litigation, has initiated an investigation on behalf of investors in Cerebras Systems Inc. (NASDAQ: CBRS). This inquiry has arisen in light of recent troubling disclosures regarding the company's performance and practices that may have impacted investor interests.
Background of the Investigation
Cerebras Systems, known for its cutting-edge silicon wafer technology aimed at revolutionizing AI and deep learning computations, went public on May 14, 2026. During its initial public offering, the company sold 30 million shares at a premium price of $185.00 each. However, the company stirred concerns among investors following its financial report for the first quarter of 2026 on June 24, 2026, where it disclosed a loss of $0.22 per share—this was significantly worse than analyst expectations of a $0.16 per share loss.
As a result of this announcement, the company’s stock took a sharp downturn, falling by 19.61% on the day following the report. Further unsettling investors, Cerebras also projected a narrower gross margin, excluding influences of customer warrants and data center pass-through revenues, raising more questions about its business strategy and financial health.
Allegations of Engineering Flaws
The situation escalated when a report from short-seller Culper Research was released on October 28, 2026. This report accused Cerebras of having significant engineering flaws within its silicon wafers, with functional lifespans purportedly limited to just 1.5 to 2.5 years—well below industry standards. The claims posited that the innovative connector material, which CEO Andrew Feldman touted as an in-house development, was rather an off-the-shelf component sourced from third-party suppliers.
Additionally, the report indicated that Cerebras was operating its wafers on a regimen of continuous